Intchains Group
ICG
Bitdeer Technologies
BTDR
NEPTUNE DIGITAL ASSETS CORP
NPPTF
MicroStrategy
MSTR
BIT Mining
BTCM
Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases. Its program targets the farnesoid X receptor, or FXR, which is central to modulating liver and GI diseases. Its FXR product candidates include MET409 and MET642.